Your browser doesn't support javascript.
loading
Intravenous Vitamin C as an Add-on Therapy for the Treatment of Sepsis in an Intensive Care Unit: A Prospective Cohort Study.
Gonzalez-Vazquez, Sergio Antonio; Gomez-Ramirez, Eli Efrain; Gonzalez-Lopez, Laura; Gamez-Nava, Jorge Ivan; Peraza-Zaldivar, Juan Angel; Santiago-Garcia, Aline Priscilla; Ramirez-Villafaña, Melissa; Gonzalez-Ponce, Fabiola; Gomez-Camarena, Jose Jorge; Saldaña-Cruz, Ana Miriam; Rodriguez-Jimenez, Norma Alejandra; Gutierrez-Aceves, J Ahuixotl; Jimenez-Lopez, Adriana; Totsuka-Sutto, Sylvia Elena; Cardona-Muñoz, Ernesto German; Ponce-Guarneros, Juan Manuel.
Afiliação
  • Gonzalez-Vazquez SA; Programa de Doctorado en Farmacología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Gomez-Ramirez EE; Unidad de Cuidados Intensivos, Hospital General Regional 110, Instituto Mexicano del Seguro Social, Guadalajara 44716, Mexico.
  • Gonzalez-Lopez L; Instituto de Terapéutica Experimental y Clínica, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Gamez-Nava JI; Instituto de Terapéutica Experimental y Clínica, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Peraza-Zaldivar JA; Programa de Maestría en Salud Publica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Santiago-Garcia AP; Instituto de Terapéutica Experimental y Clínica, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Ramirez-Villafaña M; Programa de Maestría en Salud Publica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Gonzalez-Ponce F; Programa de Doctorado en Farmacología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Gomez-Camarena JJ; Programa de Doctorado en Farmacología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Saldaña-Cruz AM; Instituto de Terapéutica Experimental y Clínica, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Rodriguez-Jimenez NA; Instituto de Terapéutica Experimental y Clínica, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Gutierrez-Aceves JA; Programa de Doctorado en Farmacología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Jimenez-Lopez A; Instituto de Terapéutica Experimental y Clínica, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Totsuka-Sutto SE; Instituto de Terapéutica Experimental y Clínica, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Cardona-Muñoz EG; Programa de Doctorado en Farmacología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Ponce-Guarneros JM; Especialistas en Medicina Critica, Hospital Terranova, Guadalajara 44670, Mexico.
Medicina (Kaunas) ; 60(3)2024 Mar 12.
Article em En | MEDLINE | ID: mdl-38541190
ABSTRACT
Background and

Objectives:

According to the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), sepsis is defined as "life-threatening organ dysfunction caused by a dysregulated host response to infection". The increased presence of free radicals causes an increase in oxidative stress. Vitamin C is an essential water-soluble vitamin with antioxidant activity and immunoregulatory effects that plays a potential role in the treatment of bacterial infections. Our aim was to evaluate the effectiveness of adding vitamin C to the conventional treatment of sepsis to decrease its mortality rate. Materials and

Methods:

In a prospective cohort study, we included patients with a diagnosis of sepsis and a SOFA score ≥ 9 who were evaluated in an Intensive Care Unit at a secondary-care hospital. According to the intensive care specialist, they were treated using two different strategies Group 1-patients with sepsis treated with conventional treatment without vitamin C; Group 2-patients with sepsis with the addition of vitamin C to conventional treatment.

Results:

We included 34 patients with sepsis. The incidence of mortality was 38%, and 47% of patients used vitamin C as an adjuvant to the basic treatment of sepsis. In the basal analyses, patients treated with use of vitamin C compared to patients treated without vitamin C required less use of glucocorticoids (75% vs. 100%, p = 0.039). At follow-up, patients treated without vitamin C had higher mortality than patients treated with vitamin C as an adjuvant for the treatment of sepsis (55.6% vs. 18.8%, p = 0.03). We observed that the use of vitamin C was a protective factor for mortality in patients with sepsis (RR 0.54, 95% CI 0.31-0.96, p = 0.03).

Conclusions:

The use of vitamin C as an adjuvant to treatment decreases the risk of mortality by 46% in patients with sepsis and SOFA ≥ 9 compared to patients treated without vitamin C as an adjuvant to sepsis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Ácido Ascórbico / Sepse Limite: Humans Idioma: En Revista: Medicina (Kaunas) Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Ácido Ascórbico / Sepse Limite: Humans Idioma: En Revista: Medicina (Kaunas) Ano de publicação: 2024 Tipo de documento: Article